AI For Pharma Growth

4/28/2026

Many pharma and life science organisations have been investing in AI for years: pilots across commercial, medical, regulatory, and R&D, innovation labs, steering committees, vendor spend, and genuine effort from smart teams. And yet the same story keeps showing up in boardrooms: ROI is unclear, adoption is patchy, and leaders struggle to explain how all the AI activity connects to strategic goals. In this solo episode, Dr Andree Bates steps into “The Diagnostic Room” to explain why this happens, and why it’s usually not a technology, talent, or speed issue. It’s a diagnosis issue: organisations often haven’t identified what is actually constraining value, so they end up executing hard on the wrong problem. Dr Andree shares a real example from a mid-sized pharma company that believed its AI programme was failing due to lack of velocity. On the surface, it was a reasonable hypothesis. But a focused diagnostic revealed three hidden structural blockers: unclear decision rights for scaling pilots into production, fragmented data ownership preventing access to the best datasets, and incentive misalignment where the people expected to adopt AI tools were not rewarded for the behaviours those tools required. She then clarifies what a diagnostic is and is not. A diagnostic is not a strategy, roadmap, vendor shortlist, financial model, or implementation plan. Instead, it provides evidence-based clarity: what’s broken, how you compare to peers, what’s at stake, and what questions have been opened that cannot responsibly be answered in ten days. That clarity creates a shared language for leadership, replacing vague frustration with a precise problem statement. Finally, Dr Andree explains why the next step after diagnosis is not “faster action”, but smarter action: a full strategic AI blueprint with proper financial modelling, governance design, sequencing, and adoption architecture. The organisations pulling ahead are not simply those with the biggest budgets, but those willing to find what’s actually broken before trying to fix it. Topics Covered Why AI initiatives can grow without creating measurable ROI The gap between pilots and a true AI strategy Misdiagnosis: executing brilliantly on the wrong problem What a diagnostic sprint is (and what it is not) Three hidden blockers: decision rights, data ownership, incentive misalignment Why working groups can’t fix structural AI constraints What a full strategic AI blueprint includes Why many AI business cases are untested projections How to improve board confidence with evidence, governance, and measurement Why diagnostics create speed by creating shared clarity Eularis helps pharma and biotech leaders turn AI activity into board-defensible strategy and measurable commercial outcomes. If your organisation has plenty of AI in motion but very little that moves the commercial needle in a way the board can see, start with our 10-Day AI Diagnostic Sprint. It’s a focused diagnostic that surfaces what’s actually broken and what’s blocking results, before you invest in a larger strategy effort. The Sprint diagnoses the problem. The AI Strategic Blueprint that follows is where we build the board-defensible strategy and plan. Details at eularis.com. About the Podcast AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr Andree Bates, created to help pharma, biotech and healthcare organisations understand how AI-based technologies can save time, grow brands, and improve company results. This show blends deep sector experience with practical conversations that demystify AI for biopharma leaders, from start-up biotech right through to Big Pharma. Each episode features experts building AI-powered tools that are driving real-world results across discovery, R&D, clinical trials, medical affairs, market access, regulatory, insights, sales, marketing, and more. Dr. Andree Bates LinkedIn | Facebook | X

4/21/2026

For many life sciences teams, the first wave of AI has looked like copilots: smart search, quick answers, and help on demand. Useful, but passive. In this episode, Dr Andree Bates is joined by Parth Khanna, CEO and co-founder of ACTO, to explore what comes next: moving beyond copilots into role-based AI agents that proactively close knowledge gaps, improve field readiness, and operate safely inside regulated environments. Parth shares his path into life sciences and tech, including founding an early NLP company in 2012 and then building ACTO after speaking with over 100 life science companies about field force effectiveness. Today, ACTO supports tens of thousands of professionals and hundreds of brand launches, and Parth argues the industry is now entering the “agentic era” where the real differentiator is not just model access, but how organisations build context, control, and change management around AI. A key theme is why generic AI tools often fail inside enterprises. Parth outlines four requirements for agent success: context (role and job-specific personalisation), connection (stitching data sources and agent-to-agent workflows), control (testing, monitoring, observability), and change management (reducing fear and driving adoption). Without these, he says, many copilots and assistants end up underused, with people quietly reverting to old workflows. Parth then introduces ACTO’s concept of role-based “super agents”, designed around a real job description (for example an MSL). Rather than a disconnected swarm of task bots, a “queen bee” orchestrator agent delegates to worker agents, checks outputs against compliance guardrails, and can be assessed with exams to quantify risk before deployment. This approach, he argues, makes AI both more powerful and safer for regulated field teams. Finally, the conversation looks ahead. Parth believes the future of work depends on pairing AI capability with distinctly human strengths: strategy, judgement, and human connection. The winners won’t be those who automate the most tasks, but those who redesign roles so humans and agents amplify each other. Topics Covered Why copilots are useful but fundamentally passive The shift from AI that responds to AI that acts Why generic tools fail: context, connection, control, change management Adoption reality: why many AI assistants go unused Quantifying risk and moving from black box to observable AI Role-based super agents and the “queen bee” orchestrator model Testing agents with exams before field deployment Guardrails, compliance, and agent-to-agent quality checks Human skills AI can’t replace: strategy, judgement, connection The future of MSL and field excellence in an agentic era Eularis helps pharma and biotech leaders turn AI activity into board-defensible strategy and measurable commercial outcomes. If your organisation has plenty of AI in motion but very little that moves the commercial needle in a way the board can see, start with our 10-Day AI Diagnostic Sprint. It’s a focused diagnostic that surfaces what’s actually broken and what’s blocking results, before you invest in a larger strategy effort. The Sprint diagnoses the problem. The AI Strategic Blueprint that follows is where we build the board-defensible strategy and plan. Details at eularis.com. About the Podcast AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr Andree Bates, created to help pharma, biotech and healthcare organisations understand how AI-based technologies can save time, grow brands, and improve company results. This show blends deep sector experience with practical conversations that demystify AI for biopharma leaders, from start-up biotech right through to Big Pharma. Each episode features experts building AI-powered tools that are driving real-world results across discovery, R&D, clinical trials, medical affairs, market access, regulatory, insights, sales, marketing, and more.

4/14/2026

Many pharma and life science organisations have been investing in AI for years: pilots across commercial, medical, regulatory, and R&D, innovation labs, steering committees, vendor spend, and genuine effort from smart teams. And yet the same story keeps showing up in boardrooms: ROI is unclear, adoption is patchy, and leaders struggle to explain how all the AI activity connects to strategic goals. In this solo episode, Dr Andree Bates steps into “The Diagnostic Room” to explain why this happens, and why it’s usually not a technology, talent, or speed issue. It’s a diagnosis issue: organisations often haven’t identified what is actually constraining value, so they end up executing hard on the wrong problem. Dr Andree shares a real example from a mid-sized pharma company that believed its AI programme was failing due to lack of velocity. On the surface, it was a reasonable hypothesis. But a focused diagnostic revealed three hidden structural blockers: unclear decision rights for scaling pilots into production, fragmented data ownership preventing access to the best datasets, and incentive misalignment where the people expected to adopt AI tools were not rewarded for the behaviours those tools required. She then clarifies what a diagnostic is and is not. A diagnostic is not a strategy, roadmap, vendor shortlist, financial model, or implementation plan. Instead, it provides evidence-based clarity: what’s broken, how you compare to peers, what’s at stake, and what questions have been opened that cannot responsibly be answered in ten days. That clarity creates a shared language for leadership, replacing vague frustration with a precise problem statement. Finally, Dr Andree explains why the next step after diagnosis is not “faster action”, but smarter action: a full strategic AI blueprint with proper financial modelling, governance design, sequencing, and adoption architecture. The organisations pulling ahead are not simply those with the biggest budgets, but those willing to find what’s actually broken before trying to fix it. Topics Covered Why AI initiatives can grow without creating measurable ROI The gap between pilots and a true AI strategy Misdiagnosis: executing brilliantly on the wrong problem What a diagnostic sprint is (and what it is not) Three hidden blockers: decision rights, data ownership, incentive misalignment Why working groups can’t fix structural AI constraints What a full strategic AI blueprint includes Why many AI business cases are untested projections How to improve board confidence with evidence, governance, and measurement Why diagnostics create speed by creating shared clarity Eularis helps pharma and biotech leaders turn AI activity into board-defensible strategy and measurable commercial outcomes. If your organisation has plenty of AI in motion but very little that moves the commercial needle in a way the board can see, start with our 10-Day AI Diagnostic Sprint. It’s a focused diagnostic that surfaces what’s actually broken and what’s blocking results, before you invest in a larger strategy effort. The Sprint diagnoses the problem. The AI Strategic Blueprint that follows is where we build the board-defensible strategy and plan. Details at eularis.com. About the Podcast AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr Andree Bates, created to help pharma, biotech and healthcare organisations understand how AI-based technologies can save time, grow brands, and improve company results. This show blends deep sector experience with practical conversations that demystify AI for biopharma leaders, from start-up biotech right through to Big Pharma. Each episode features experts building AI-powered tools that are driving real-world results across discovery, R&D, clinical trials, medical affairs, market access, regulatory, insights, sales, marketing, and more. Dr. Andree Bates LinkedIn | Facebook | X

4/7/2026

AI ethics has moved from theory to urgent necessity, especially as AI systems become embedded in healthcare, business decisions, and society at large. In this episode, Dr Andree Bates is joined by Dr Nadia Morozova, founder of Enriched Insights, to unpack what ethical AI really means in practice, and how organisations can innovate quickly without creating risk, bias, or governance failures. Nadia shares insights from the global conversation on AI ethics, including discussions at Davos, and explains why trust is becoming the true competitive advantage. She argues that organisations should use AI to build stronger, more open relationships with customers and stakeholders, where technology acts as an enabler rather than the centrepiece. The conversation then gets practical. Nadia outlines a human-centric framework for high-quality AI outcomes, covering accurate sampling, futureproofing (because models are trained on the past), data connectivity across sources, and responsible blending of human and synthetic data. She warns that leadership teams often treat AI as “magic”, assuming tools will solve complex problems like data harmonisation without the hard work of ontology, governance, and expert oversight. A real-world example brings this to life: the Zillow case, where initial success collapsed as market dynamics shifted and the model failed to adapt in time, leading to huge losses. For Nadia, the lesson is clear: ethical responsibility is not a checkbox at launch, it requires ongoing monitoring, review, and culture change. Nadia closes with a strategic message for leaders: start with business goals and targeted use cases, involve data experts early, build governance upfront, and keep humans in the loop throughout the AI lifecycle. Done properly, ethical AI is not a constraint on innovation, it is how you protect long-term value and trust. Topics Covered Why AI ethics is now an urgent business and societal issue Trust, transparency, and accountability in AI deployment Human centricity as the foundation of high data quality Accurate sampling and avoiding “biased reality” in models Why futureproofing matters when algorithms learn from the past Data connectivity, governance, and the ontology problem Responsible blending of human and synthetic data Dangerous leadership assumptions about AI “magic” The Zillow case and what happens without ongoing oversight Strategy first: KPIs, targeted use cases, and right-sized models Skills gaps: technical roles, business acumen, and cross-functional teams Culture change and post-deployment monitoring About the Podcast AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr Andree Bates, created to help pharma, biotech and healthcare organisations understand how AI-based technologies can save time, grow brands, and improve company results. This show blends deep sector experience with practical conversations that demystify AI for biopharma leaders, from start-up biotech right through to Big Pharma. Each episode features experts building AI-powered tools that are driving real-world results across discovery, R&D, clinical trials, medical affairs, market access, regulatory, insights, sales, marketing, and more. Dr. Andree Bates LinkedIn | Facebook | X

3/31/2026

Digital biomarkers are turning everyday movement into clinically useful data, giving doctors a clearer picture of what’s happening between appointments, and giving pharma new ways to measure drug impact earlier and more precisely. In this episode, Dr Andree Bates interviews Dr Quique Llaudet, CEO and co-founder of Ephion Health, about precision monitoring and how AI-driven mobility analysis is changing both clinical care and drug development. Quique shares his journey from academic research into entrepreneurship, driven by a desire to turn science into real products that help patients. Ephion Health grew out of early work with paediatric hospitals in Barcelona, where sensor technology used in rehabilitation and exoskeleton projects revealed a bigger opportunity: objective, high-sensitivity gait and movement analysis that can detect disease signatures and track progression over time. The conversation breaks down what a digital biomarker actually is: a measurable signal of health captured via connected devices and analysed with digital methods. Ephion’s platform integrates multiple validated, off-the-shelf sensors to capture rich movement data in a short test, replacing blunt measures like the six-minute walk test with something both more sensitive and less stressful for patients. The system then combines key parameters into a single composite score to track progression and treatment response. Quique also tackles the “black box” concern head on. He explains how their models are developed alongside clinicians, with clinical relevance checked throughout, and how doctors can inspect the underlying parameters behind the biomarker score in a dashboard. For rare diseases with limited data, he highlights deep collaboration with clinicians and patient associations, and the use of synthetic data to support modelling and testing. Finally, Quique outlines the economics: reducing specialist assessment time, enabling more frequent remote monitoring, supporting earlier treatment adjustments, and helping pharma generate evidence in real-world settings. The long-term vision is continuous monitoring that helps clinicians act earlier, plus AI-assisted diagnosis and eventually prevention. Topics Covered What digital biomarkers are and how they differ from traditional biomarkers Turning mobility data into clinically meaningful signals Multi-sensor monitoring: IMUs, pressure insoles, and EMG Why short tests can beat the six-minute walk test Composite biomarker scoring and tracking treatment response AI patterns clinicians may sense but cannot quantify Explainability and building models “hand in hand” with doctors Data challenges in rare disease and the role of patient associations Synthetic data for modelling and validation Economic impact: time savings, remote monitoring, and better treatment adjustment Pharma use cases: real-world evidence and earlier efficacy signals in trials About the PodcastAI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr Andree Bates, created to help pharma, biotech and healthcare organisations understand how AI-based technologies can save time, grow brands, and improve company results. This show blends deep sector experience with practical conversations that demystify AI for biopharma leaders, from start-up biotech right through to Big Pharma. Each episode features experts building AI-powered tools that are driving real-world results across discovery, R&D, clinical trials, medical affairs, market access, regulatory, insights, sales, marketing, and more. Dr. Andree Bates LinkedIn | Facebook | X

3/25/2026

Digital twins have become one of the most promising tools in Alzheimer’s research, but the bigger story is what happens when they scale across disease areas. In this episode, Dr Andree Bates interviews Aaron Smith, Founder and Head of Machine Learning at Unlearn AI, about how “digital twin generators” can transform trial design by modelling realistic patient progression and improving statistical power without compromising the fundamentals of randomised controlled trials. Aaron shares his journey from academic mathematics into computer vision and machine learning, then into biopharma, where Unlearn began by building generative models that learn the joint distribution of clinical variables. In practice, that means the model can take baseline patient measurements and generate likely future progressions that are as indistinguishable from real clinical records as possible. The conversation dives into a key misconception: digital twins are not only about replacing control arms. Aaron explains a regulatory friendly approach where you keep standard trial structure, but add counterfactual information for every patient into the analysis. Unlearn’s best known method, ProCOVA (prognostic covariate adjustment), summarises a predicted control outcome per patient and uses it for covariate adjustment, creating more efficient treatment effect estimates. The headline result is simple: you can increase power, or reduce recruitment burden while maintaining power, potentially speeding time to results. Finally, Aaron explains why scaling across diseases is genuinely hard. Data structures differ wildly by indication, missingness can block transfer learning, and areas like oncology require modelling complex treatment histories. He also highlights that combining sources is not just “more data”, it demands careful harmonisation and context modelling to avoid biased predictions, especially when bringing in real world evidence. Topics Covered What “digital twin generators” are in clinical trials Generative modelling of clinical records and disease progression Counterfactual prediction under standard of care Why replacing control arms is not the only use case ProCOVA and prognostic covariate adjustment Getting more statistical power and reducing trial size FDA openness to digital twins in trials and what it enables Why scaling across disease areas is not just parameter tuning Missing data, confounding context, and data harmonisation CNS versus oncology modelling challenges Real world evidence and how to validate digital twin models About the Podcast AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr Andree Bates, created to help pharma, biotech and healthcare organisations understand how AI-based technologies can save time, grow brands, and improve company results. This show blends deep sector experience with practical conversations that demystify AI for biopharma leaders, from start-up biotech right through to Big Pharma. Each episode features experts building AI-powered tools that are driving real-world results across discovery, R&D, clinical trials, medical affairs, market access, regulatory, insights, sales, marketing, and more. Dr. Andree Bates LinkedIn | Facebook | X

3/18/2026

AI in drug development is moving beyond “failure prevention” into something much bigger: redesigning how we discover, develop, and deliver medicines. In this episode, Dr Andree Bates speaks with Vitalay Fomin of Numenos about biomarker discovery, patient stratification, and why the next breakthroughs come from breaking down data silos across diseases, modalities, and even species. Vitalay shares his background across biotech and pharma, including work in biomarker discovery, translational medicine, and data science, and how frustration with existing approaches led her to build a new architecture for clinical genomic insights. A core theme is that traditional methods often oversimplify biology by forcing outcomes into binary labels and treating each disease area as an isolated box, even when the available data is too limited to answer meaningful questions well. The conversation explores how foundation model approaches can unify clinical, genomic, transcriptomic, proteomic and imaging signals to create a fuller “biological fingerprint” of each patient. Vitalay explains how this can enable earlier insight from single-arm trials by effectively benchmarking against standard-of-care cohorts, helping teams enrich later-stage trials with the right subpopulations sooner, and reducing time and cost. They also discuss the real blockers to adoption: not only scientific conservatism, but commercial uncertainty around how Big Pharma structures deals with tech-bio companies that bring platforms rather than single assets. Vitalay argues that explainability is non-negotiable in this space, because clinicians, scientists, patients, and regulators will not trust black-box predictions. Topics Covered Why AI is shifting from failure prevention to pipeline redesign Biomarker discovery beyond binary responder vs non-responder labels Breaking disease silos to learn across indications Multimodal integration: DNA, RNA, protein, imaging, and clinical data Using foundation models to bridge trial data and real-world data Patient stratification and trial enrichment from early studies Reverse translation and identifying unmet need before target hunting Explainability, trust, and regulatory readiness Adoption barriers: culture, champions, and deal structures for tech-bio Misconceptions about AI in drug development and why “press a button” is a myth About the Podcast AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr Andree Bates, created to help pharma, biotech and healthcare organisations understand how AI-based technologies can save time, grow brands, and improve company results. This show blends deep sector experience with practical conversations that demystify AI for biopharma leaders, from start-up biotech right through to Big Pharma. Each episode features experts building AI-powered tools that are driving real-world results across discovery, R&D, clinical trials, medical affairs, market access, regulatory, insights, sales, marketing, and more. Dr. Andree Bates LinkedIn | Facebook | X

3/11/2026

Enterprise AI is shifting from experiments to infrastructure, and that changes everything. In this episode, Dr Andree Bates interviews Jocelyn Houle, Senior Director of Product Management at Securiti.ai, to explore the future of enterprise AI, agents, automation, and the single biggest blocker to scale: trust. Jocelyn shares what she is seeing across highly regulated industries as organisations move beyond proof of concept into production. She explains why the agent era raises the stakes: when you add LLMs into workflows, systems become non-deterministic and harder to trace end to end. In her words, once the data goes in, you cannot easily untangle it, so organisations need stronger controls around permissions, auditing, and policy enforcement. A major theme is that data foundations matter more than ever. Jocelyn warns that agents will not magically repair messy data, they will expose weak data quality immediately. From there, she outlines how trust can be won or lost at the prompt layer, both outbound (what the model says to customers) and inbound (what users share with the organisation). She also discusses “toxic combinations”, where overlapping access can accidentally leak sensitive information, plus the growing need for prompt screening and tracking to reduce risk. The conversation also digs into explainability and auditability, with Jocelyn being refreshingly honest that the perfect solution is not here yet. Instead, enterprises are using practical approaches like benchmarking releases side by side, cataloguing AI agents in use, and building governance that is starting to look more like modern cybersecurity: baked in from the start, not added as an afterthought. Jocelyn closes with clear advice for leaders: start “left” with raw data controls, build a truly cross-functional team, and begin setting up auditability even with imperfect tools, because regulators are catching up and they will expect responsible behaviour. Topics Covered Where enterprise AI adoption really stands today What makes AI agents different from traditional automation Non-determinism, traceability, and why permissions matter Data mapping, policy controls, and reducing sensitive data leakage Prompt security: outbound and inbound trust risks “Toxic combinations” and exposure through agent workflows Explainability, benchmarking, and parallel release testing AI governance becoming as essential as cybersecurity Top 3 pieces of advice for CTOs starting their AI journey Why enterprise AI will become so embedded we stop talking about it AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr Andree Bates, created to help pharma, biotech and healthcare organisations understand how AI-based technologies can save time, grow brands, and improve company results. This show blends deep sector experience with practical conversations that demystify AI for biopharma leaders, from start-up biotech right through to Big Pharma. Each episode features experts building AI-powered tools that are driving real-world results across discovery, R&D, clinical trials, medical affairs, market access, regulatory, insights, sales, marketing, and more. Dr. Andree Bates LinkedIn | Facebook | X About the Podcast

3/4/2026

Clinical trials are a massive industry with brutal economics, long timelines, and failure rates that would be unacceptable in almost any other sector. In this episode, Dr Andree Bates is joined by Dr Joseph Geraci of NetraMark to break down why trials fail so often, how patient heterogeneity drives cost and uncertainty, and where AI can realistically shift the economics. Joseph shares his unusual path from mathematics and mathematical physics into oncology and medical science, including a decision to move into hospital research rather than follow a more traditional academic route. That shift shaped his focus: not just discovering more molecules, but understanding why the same drug can work brilliantly for some patients and fail for others. A central theme is that clinical trials are not “one disease, one patient type”. In many areas, disease definitions are too broad for trial design, making trials feel like trying to hit multiple dartboards with one dart. Joseph explains how NetraMark’s approach aims to identify meaningful subpopulations inside small datasets, finding the “pocket” where a drug’s true advantage shows up, without discarding patients as outliers. The conversation also touches on regulators, including growing interest in innovation pathways, but also the fear pharma teams have about changing protocols and risking setbacks. Joseph argues that AI’s biggest economic value in trials is speed, using better insight from limited trial data to guide enrichment strategies, smarter substudy decisions, and faster iteration, especially in oncology and rare disease where time is everything. Topics Covered Why clinical trial economics are becoming unsustainable Patient heterogeneity and why disease definitions break trials Finding “pockets” of responders within small datasets Trial enrichment and substudies that reveal a drug’s advantage Why pharma adoption can be slow, even when failures are constant Regulatory interest, guidelines, and sponsor risk aversion Large language models vs mathematically augmented AI approaches Speed as the biggest economic lever in trials Practical examples across depression, schizophrenia, oncology, and beyond What clinical trials could look like in five years with AI-driven insight This show blends deep sector experience with practical conversations that demystify AI for biopharma leaders, from start-up biotech right through to Big Pharma. Each episode features experts building AI-powered tools that are driving real-world results across discovery, R&D, clinical trials, medical affairs, market access, regulatory, insights, sales, marketing, and more.  Dr. Andree Bates LinkedIn | Facebook | X

2/25/2026

AI capability has never been higher, yet most pharma AI programmes are still failing to create measurable business impact. In this solo episode, Dr Andree Bates breaks down why many pharma and biotech AI strategies are “broken before they even begin” and what a real AI strategic blueprint needs to include if you want adoption, scale, and outcomes, not just impressive pilots. Dr Andree explains the core paradox: AI can now synthesise literature at speed, accelerate discovery, and outperform human experts in specific tasks, but the business results are often disappointing because the failure is rarely technical. It is strategic. She describes the “technical obsession trap”, where organisations spend months optimising models and benchmarking competitors while adoption remains low and teams are not operationally ready to act on the outputs. She outlines three common failure modes: Innovation Theatre, where disconnected pilots never compound into enterprise value Competitor benchmarking, where companies copy use cases that do not fit their context Technology first strategy, where tools are bought before priorities are defined From there, she maps what a strong pharma AI blueprint must cover: grounding in business objectives, end to end deployment architecture (data, governance, capability, change), leadership and culture, rigorous financial modelling tied to revenue and ROI, and alignment across functions including commercial, medical, regulatory, R&D, market access, insights, and tech teams. Dr Andree closes with a clear challenge for leadership: competitive advantage will come to organisations that build the most intelligent operating model around AI, not those with the biggest budgets. She also offers a 45 minute AI strategic diagnostic for pharma and biotech leaders who want an honest read on what to fix before investing further. Topics Covered Why pharma AI impact often disappoints despite powerful tools The “technical obsession trap” and the AI strategy blind spot Innovation Theatre, competitor benchmarking, and technology first mistakes What a pharma AI strategic blueprint must include Governance as a foundation for scale and regulatory trust Leadership, culture, and adoption as the real differentiators Financial modelling and prioritisation based on ROI and revenue impact Organisational alignment across the full pharma value chain Choosing the right advisory partner and avoiding generic frameworks Why strategy must come before technology to build durable advantage AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr Andree Bates, created to help pharma, biotech and healthcare organisations understand how AI-based technologies can save time, grow brands, and improve company results. This show blends deep sector experience with practical conversations that demystify AI for biopharma leaders, from start-up biotech right through to Big Pharma. Each episode features experts building AI-powered tools that are driving real-world results across discovery, R&D, clinical trials, medical affairs, market access, regulatory, insights, sales, marketing, and more. Dr. Andree Bates LinkedIn | Facebook | X

2/18/2026

Healthcare accessibility is still being held hostage by phone queues, missed calls, and clunky portals. In this episode, Dr Andree Bates sits down with Josh Taylor of TxtSquad to explore why simple, secure texting can remove friction for patients and providers, and how AI can support the conversation without making care feel robotic. Josh explains why SMS works where apps often fail: it is familiar, low effort, and asynchronous. That means patients can reply on their own time, while care teams can manage conversations in a way that fits real clinic workflows instead of forcing everyone into yet another platform. They dig into the pharma and adherence angle too. Josh shares how two-way messaging helps teams move beyond generic reminders and uncover the real reasons people stop taking medication, opening the door to earlier support, smarter interventions, and better outcomes. Finally, Josh outlines where AI adds value inside messaging: triage for common questions, translation, summarisation, and staff copilots. He also highlights the importance of compliance, clear boundaries, and human oversight when dealing with sensitive health information. The future, he suggests, is smarter communication across SMS, voice, and phone-based assistants, designed to meet patients where they already are. Topics Covered Why portals and apps struggle with adoption in healthcare SMS as a low-barrier, asynchronous engagement channel Building a two-way patient to provider communication loop Medication adherence: understanding drop-off, not just sending reminders Patient assistance programmes and support at scale Clinical trial recruitment and retention using messaging AI in messaging: triage, translation, summarisation, and staff copilots Compliance considerations and handling sensitive information What comes next: voice agents and deeper integration with phone workflows About the Podcast AI for Pharma Growth is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget. As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses. This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business Dr. Andree Bates LinkedIn | Facebook | X

2/11/2026

As artificial intelligence becomes increasingly woven into everyday life, the real question isn’t just what AI can do — it’s what it should do for humans. In this episode, Dr Andree Bates interviews Dr Morteza Zihayat of Heisenberg Network to explore Human-Centred AI: designing intelligent systems that prioritise welfare, autonomy, dignity and trust over pure technical capability. Morteza explains how his background in data mining led to a key insight: numbers can be incredibly powerful, but they still “miss the mark” when human values are ignored. That perspective shaped his work in Human-Centred AI and helped inspire Heisenberg Network, a decentralised infrastructure designed to transform fragmented, messy data into high-quality, AI-ready intelligence — in minutes rather than weeks — while dramatically reducing cost. The conversation digs into what human-centred design looks like in practice. Morteza introduces a “ladder of priorities” to manage conflicting values — from safety and laws at the top, through ethics and platform policies, down to individual preferences — and argues that making this ladder public gives people a right to debate and appeal decisions when something feels wrong. Finally, Morteza tackles the unavoidable trade-offs between performance and fairness, sharing a real example from mental health research where reducing model accuracy produced a fairer system that clinicians felt more comfortable using. His key message is urgent: powerful AI is coming either way — making it human-centred is a choice we need to commit to now, with transparency becoming non-negotiable. Topics Covered What Human-Centred AI means in practice Turning user stories into concrete design checks The “ladder of priorities” for managing conflicting values Designing systems for welfare, autonomy, dignity and trust Power caps and keeping AI controllable Personalisation vs wellbeing (and avoiding filter bubbles) Where bias enters: data, models, and feedback loops Debiasing pipelines and fairness as real-world data shifts Learning from users without storing raw personal data Explainability challenges with reasoning models Why transparency is becoming non-negotiable When less accuracy can be the more responsible choice About the Podcast AI for Pharma Growth is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget. As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses. This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business. Dr. Andree Bates LinkedIn | Facebook | X

2/4/2026

Designing proteins that have never existed in nature is no longer sci-fi — it’s becoming a real drug discovery strategy. In this episode, Kashif Sadiq, Founder & CEO of DenovAI Biotech, explains how AI is powering a shift from searching for biologic binders to intentionally designing new proteins from scratch. Kashif shares his journey from studying physics at University of Cambridge into computational biophysics, and how breakthroughs like AlphaFold from DeepMind helped unlock the next frontier: de novo protein design. Instead of hoping evolution has already produced a usable molecule, Kashif describes how modern AI can engineer bespoke proteins for specific functions, including challenging targets where traditional approaches come up short. The conversation dives into the sheer scale of “protein space” and why evolution has only explored a tiny fraction of what’s possible. Kashif outlines how this opens the door to targeting diseases and biological mechanisms that have historically been considered undruggable, especially where flat protein interfaces or complex signalling pathways have made small molecules ineffective. Finally, Kashif explains why combining generative AI with physics-based methods is essential to reduce false positives, improve real-world binding performance, and enable “one-shot design” — where discovery and optimisation become a single integrated process. He also shares what keeps him up at night: clinical trial attrition — and why designing better earlier may be the key to improving success later. Topics Covered De novo protein design vs traditional biologics discovery Why evolution explored only a tiny fraction of protein space “Programmable biologics” and intentional molecular design Alpha Design and designing proteins from the inverse problem Antibodies, nanobodies, and therapeutic protein engineering Combining generative AI with physics-based validation Reducing false positives in protein binding predictions “One-shot design” and compressing discovery timelines Undruggable targets, flat interfaces, and intracellular signalling Clinical trial attrition and what’s missing at the preclinical stage When the first de novo-designed therapeutic could enter trials About the Podcast AI for Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr Andree Bates, created to help pharma, biotech and healthcare organisations understand how AI-based technologies can save time, grow brands, and improve company results. This show blends deep sector experience with practical, no-fluff conversations that demystify AI for biopharma execs — from start-up biotech right through to Big Pharma. Each episode features experts building AI-powered tools that are driving real-world results across discovery, R&D, clinical trials, market access, medical affairs, regulatory, insights, sales, marketing, and more. Dr. Andree Bates LinkedIn | Facebook | X

1/28/2026

Large Language Models (LLMs) are moving far beyond text generation—and into the heart of scientific discovery and pharmaceutical research. In this episode, Javier Tordable, founder and CEO of Pauling.ai and former Google technologist, explains how agentic AI systems are transforming early-stage drug discovery. Javier shares how modern LLMs differ from earlier generations, highlighting their ability to perform autonomous, multi-step scientific workflows rather than isolated tasks. These AI agents can read and synthesize massive volumes of scientific literature, generate novel hypotheses, validate ideas against published research, and accelerate computational chemistry simulations that once took months or years. The discussion dives into how LLMs are being used today to identify drug targets, design molecules, optimize clinical trials, and reduce manual scientific labor, while still preserving the critical role of human creativity and experimental validation. Javier also addresses the real risks—hallucinations, data quality, reproducibility—and why hybrid AI + physics-based approaches are essential for trustworthy results. This episode is a must-listen for researchers, founders, and operators exploring LLMs in biotech, pharma AI, scientific automation, and computational drug discovery. Topics Covered Large Language Models (LLMs) in science and pharma AI agents and autonomous research workflows Early-stage drug discovery acceleration Computational chemistry and molecular simulations AI-assisted literature review and hypothesis generation Clinical trial optimization with AI Reducing R&D timelines and operational bottlenecks Risks, hallucinations, and validation in scientific AI About the Podcast AI for Pharma Growth is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget. As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses. This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more. Dr. Andree Bates LinkedIn | Facebook | Twitter

1/21/2026

Artificial intelligence is rapidly reshaping the pharmaceutical industry—and nowhere is that more evident than in small-molecule drug discovery. In this episode, we sit down with Tom Shani, CEO and co-founder of ProPhet, an AI-driven biotech company focused on discovering drugs for hard-to-target proteins. Tom explains how machine learning models, transformers, and AI-driven molecular representations are overcoming the biggest limitations of traditional drug discovery: slow timelines, high failure rates, missing data, and billion-dollar R&D costs. Rather than relying solely on physics-based simulations and trial-and-error lab work, AI systems learn patterns directly from noisy biological data—making them uniquely suited for real-world biology. The conversation explores how AI can compress drug discovery timelines from decades to years, reduce failed trials, and dramatically lower costs by improving early-stage target and molecule selection. Tom also breaks down why small molecules remain the backbone of modern medicine, how AI enables scalable exploration of vast chemical space, and why trust, regulation, and validation remain the biggest hurdles to adoption. This episode is essential listening for anyone working in pharma R&D, biotech, AI-driven drug discovery, computational biology, or life sciences innovation. Topics Covered AI-powered small-molecule drug discovery Machine learning vs traditional pharmaceutical R&D Hard-to-drug proteins and undruggable targets Transformers, AlphaFold, and molecular representations Reducing drug discovery timelines and costs AI robustness to missing and noisy biological data Off-target effects, toxicity, and safety prediction The future of AI in pharma and biotech startups About the Podcast AI for Pharma Growth is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget. As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses. This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more. Dr. Andree Bates LinkedIn | Facebook | Twitter

1/14/2026

In this episode, Dr. Andre Bates, Founder & CEO of Eularis, joins Cures and Capital hosts Martin and Simona to explore how artificial intelligence is transforming drug discovery, R&D productivity, and enterprise strategy across the biopharma industry. Dr. Andre Bates shares a pragmatic view on AI in the biopharma industry, cutting through the hype to explore where AI is already delivering value and where companies need to focus for real impact. From regulatory document preparation to AI-driven drug discovery, Andre explains how AI is transforming the industry—and why human adoption is just as critical as the technology itself. What You’ll Learn from This Episode: The “low-hanging fruit” for AI in pharma, including regulatory, clinical, and medical affairs applications. How AI is accelerating drug discovery, clinical trials, and predictive healthcare. The importance of human trust and adoption in successful AI implementation. Predictions for AI-driven transformations in business models, digital twins, and disease prevention. Practical steps for building a disciplined AI strategy with measurable ROI. About the Podcast AI for Pharma Growth is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget. As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses. This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more. Dr. Andree Bates LinkedIn | Facebook | Twitter

1/7/2026

In this episode, Dr. Andre Bates, Founder & CEO of Eularis, joins Cures and Capital hosts Martin and Simona to explore how artificial intelligence is transforming drug discovery, R&D productivity, and enterprise strategy across the biopharma industry. Dr. Bates shares actionable insights into the real-world potential of AI to reduce time-to-market, cut development costs, and create competitive advantage. From AI strategy alignment with business goals to executive board responsibilities and data governance, this episode dives deep into what it takes to implement AI successfully across the pharmaceutical value chain. What You’ll Learn in This Episode: How AI can accelerate drug discovery and clinical trials, potentially reducing costs and time-to-market by up to 50–60%. Why many pharma companies are struggling to convert AI pilots into measurable business outcomes. The importance of connecting AI initiatives to strategic business objectives, rather than treating them as isolated tech projects. Key roles for the CEO, CFO, R&D leaders, and board directors in driving enterprise-wide AI adoption. How to identify "pockets of excellence" in AI implementation and the path to fully integrated AI in pharma. Practical guidance on leveraging company data for AI while avoiding common pitfalls. Emerging trends like digital twins, synthetic data, and multimodal AI for the life sciences sector. Whether you’re a pharma executive, AI strategist, or R&D professional, this episode provides a comprehensive roadmap to harness AI for sustainable innovation and measurable ROI in biopharma. About the Podcast AI for Pharma Growth is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget. As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses. This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more. Dr. Andree Bates LinkedIn | Facebook | Twitter

12/31/2025

In this episode, Dr. Andre Bates, Founder & CEO of Eularis, joins Cures and Capital hosts Martin and Simon for a deep dive into how AI is transforming the biopharma industry. With over two decades of experience applying AI across R&D, clinical development, regulatory, medical affairs, and commercial teams, Dr. Bates explains how the field has evolved from early digitisation to the current generative AI era. She discusses the post-ChatGPT shift in executive decision-making, why many organisations are stuck in endless piloting, and how companies can build a strategic, business-aligned AI roadmap that delivers real-world value. Dr. Bates also breaks down a practical framework for calculating ROI on AI initiatives and highlights where pharma teams are seeing the strongest impact today—from drug discovery and clinical trials to regulatory workflows and personalised commercial engagement. What You’ll Learn From This Episode How AI has evolved in biopharma over the past two decades. Why ChatGPT created a turning point for pharma executives. Common pitfalls that cause AI pilots to fail—and how to avoid them. How to build a strategic, outcome-driven AI roadmap. A practical framework for calculating ROI on AI initiatives. Where AI delivers the highest ROI across the pharma value chain. How AI can elevate—not replace—the expertise of scientific, clinical, and medical teams. About the Podcast AI for Pharma Growth is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget. As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses. This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more. Dr. Andree Bates LinkedIn | Facebook | Twitter

12/24/2025

In this episode, we take you inside the AI factory — the place where companies are transforming real business operations using AI workflows, not just experimenting with flashy demos or proofs of concept. AI strategist Dustin Jensen breaks down what differentiates AI systems that scale from those that become expensive experiments. He explains why companies waste money when they “throw AI at a workflow” without truly understanding the process, the data, and the human-in-the-loop requirements. You’ll hear how to build AI workflows that integrate with existing infrastructure, collaborate with people, and close the loop on real tasks — not copilots that need constant oversight. What You’ll Learn: What an AI factory actually is and how it works How to turn AI pilots into production-grade systems The role of workflow discovery and data flow mapping Why most AI deployments fail due to poor data quality and lack of readiness How to design systems where humans and AI collaborate seamlessly The mindset shift employees need when adopting generative AI tools The difference between copilots and AI agents that close the loop on tasks How to build AI with safety, reliability, and error-handling designed in Why small, specialized agents outperform “monolithic” do-everything models About the Podcast AI for Pharma Growth is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget. As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses. This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more. Dr. Andree Bates LinkedIn | Facebook | Twitter

12/17/2025

In today’s episode, we explore the Simplify to Scale approach — how companies can use AI, intelligent automation, and design thinking to remove operational friction, improve workflows, and unlock sustainable growth. Our guest, Anthony Franco, is a serial entrepreneur, AI strategist, and co-author of AI First Principles and The Wiser Method. He has launched and successfully exited six companies, and now advises enterprise leaders on how to operationalize AI safely and strategically. You'll learn how to identify the difference between necessary complexity (the kind that creates competitive advantage) and unnecessary complexity (the kind that wastes time, budget, and energy). Anthony also reveals why most companies fail with AI implementation — and how the right simplification process prevents wasted effort. If you're a founder, CEO, COO, or operator who wants to grow without adding more tools, processes, or people, this episode shows how to scale smarter, not bigger. What You’ll Learn The Simplify to Scale methodology How to combine AI + design thinking to streamline operations Why complexity can be a competitive differentiator The #1 mistake companies make when implementing AI How to identify process friction and hidden inefficiencies Why AI won’t take jobs — but will eliminate monotonous work How to build human-in-the-loop systems (AI + people working together) Metrics to track success: cycle time, velocity, exceptions, cost reduction About the Podcast AI for Pharma Growth is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget. As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses. This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more. Dr. Andree Bates LinkedIn | Facebook | Twitter

12/10/2025

What if drug testing didn’t need animals — or risky early-stage human trials? In today’s episode, we explore organ-on-a-chip technology, a breakthrough innovation that is transforming how drugs are developed, tested, and brought to market. These micro-sized devices — containing real living human cells — can accurately replicate the function of organs like the liver, lungs, brain, kidney, and intestine. Our guest, Daniel Levner, Chief Technology Officer and co-founder of Emulate, breaks down how this technology works, why the FDA is recognizing it as an alternative to animal testing, and how it’s already being used by leading pharma companies to predict toxicity, reduce failures in clinical trials, and accelerate drug development. What You’ll Learn in This Episode Why 90% of new drugs fail in clinical trials — and how organ chips solve that problem. How living human cells inside microfluidic channels behave like real organs. Why organ-on-a-chip is more accurate than traditional cell cultures and animal testing. How pharma companies like Moderna are already using organ chips to avoid costly primate testing. How linking multiple organ chips could create “a human-on-a-chip” system. The impact on rare disease research, CRISPR-based disease modeling, and personalized medicine. How organ chips could save the pharma industry $3B+ annually and lower drug costs for patients. About the Podcast AI for Pharma Growth is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget. As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses. This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more. Dr. Andree Bates LinkedIn | Facebook | Twitter

12/3/2025

In this episode, we explore one of the most disruptive advancements currently reshaping the pharmaceutical and biotech industry: AI-powered digital twins for clinical trials. Our guest, Aaron Smith, PhD — Founder and Head of Machine Learning at Unlearn.AI — breaks down how digital twins and generative AI are transforming drug development by enabling faster, smaller, and more efficient clinical trials. Unlearn.AI builds digital twin models: virtual patient replicas created using clinical trial data, registry data, and real-world data. These digital twins allow researchers to simulate how a patient’s disease will progress under standard care, long before a clinical trial is completed. When combined with randomized controlled trials, this technology reduces data variability, increases trial power, and can dramatically shrink sample sizes and timelines. Some pharma companies are already estimating a six-month reduction in time-to-market, with millions saved in development and operational costs. What You’ll Learn What digital twins are and how they simulate patient outcomes using real-world clinical data. How AI is enabling smaller Phase III trials without sacrificing statistical power. Why digital twins are helping pharma identify which patients are most likely to benefit from specific treatments. The biggest barriers to adopting AI in drug development (hint: it’s not the regulators — it’s culture). Trends shaping the future of clinical trials and precision medicine over the next 10 years. Digital twins reduce variability and increase power by predicting how each patient would progress under standard care. The approach (called Prognostic Covariate Adjustment / ProCova) can be used in traditional randomized controlled trials. Pharma partners expect significant reductions in trial timelines and costs. AI enables precision trial design by identifying the most prognostic patient features and outcome measures. About the Podcast AI for Pharma Growth is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget. As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses. This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more. Dr. Andree Bates LinkedIn | Facebook | Twitter

11/26/2025

What if artificial intelligence could detect throat cancer instantly — in real time — during a routine exam? In this groundbreaking episode, we speak with Marius Wellenstein, Founder and CEO of WSK Medical, the company behind the world’s first AI-powered endoscopic solution for real-time detection and classification of throat and head & neck cancers. Marius shares how his team developed a plug-and-play AI system that integrates seamlessly into existing endoscopy equipment to identify both benign and malignant lesions within seconds — helping ENT surgeons catch cancers earlier, reduce diagnostic delays, and save lives. He also discusses how AI is redefining clinical workflows, accelerating cancer diagnostics, and bringing expert-level accuracy to every outpatient clinic, no matter its size. If you’re interested in the future of AI in medicine, oncology innovation, or digital health entrepreneurship, this episode is a must-listen. Key Highlights How Marius identified the gap between AI innovation and real-world clinical use The technology behind AI-powered laryngoscopy and how it works in real time Training the model on over 80,000 medical images and 1,000+ patient cases How AI can cut cancer diagnosis from weeks to same-day results Why WSK Medical’s plug-and-play AI can fit any ENT or endoscopy setup Lessons in bringing AI innovation into conservative healthcare systems The life-saving potential of early cancer detection through accessible AI tools What’s next for WSK Medical — expanding from throat cancer to other cancer types About the Podcast AI for Pharma Growth is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget. As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses. This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more. Dr. Andree Bates LinkedIn | Facebook | Twitter

11/19/2025

In this episode, we sit down with Dr. William Ho, President, CEO, and Co-Founder of IN8 Bio — a pioneering biotech company developing next-generation Gamma Delta T cell therapies for both solid and hematologic cancers. From Wall Street to the biotech lab, Dr. Ho shares his remarkable journey and how he’s leveraging artificial intelligence, data analytics, and computational biology to reshape cell therapy development, manufacturing, and scalability. Discover how AI is transforming every stage of biotech — from drug discovery and clinical trial optimization to manufacturing automation and investor relations — and why Dr. Ho believes it’s key to achieving IN8 Bio’s mission of Cancer Zero. Key Highlights From finance to pharma: How Dr. Ho’s Wall Street experience shaped his approach to building a public biotech company. AI in biotech innovation: Real-world examples of using natural language processing and machine learning to uncover drug-development gaps. Data-driven discovery: How IN8 Bio uses AI, RNA Seq, and single-cell analysis to advance Gamma Delta T cell therapies. Smarter manufacturing: The role of AI and LLMs in optimizing cell-therapy production, reducing costs, and managing global supply chains. Regulatory readiness: How biotech companies can navigate FDA compliance while integrating AI tools. Capital markets & biotech: Why the next generation of investors discover biotech companies on TikTok — and how IN8 Bio adapts to the algorithmic market. Mission Cancer Zero: How AI will help achieve a future where no patient dies of cancer. About the Podcast AI for Pharma Growth is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget. As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses. This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more. Dr. Andree Bates LinkedIn | Facebook | Twitter

11/12/2025

In this episode, we explore the future of medicine beyond artificial intelligence with Joseph Geraci — mathematician, medical scientist, and quantum machine learning pioneer. While today’s AI breakthroughs and large language models (LLMs) have transformed diagnostics, data analysis, and drug discovery, quantum computing could completely redefine what’s possible in healthcare. Dr. Geraci breaks down how quantum algorithms, molecular simulations, and quantum machine learning could unlock a new era of precision medicine, drug discovery, and disease taxonomy — computing biology at the speed of biology itself. He also explains: What makes quantum computation fundamentally different from classical AI Why current AI models like ChatGPT and medical LLMs face memory and accuracy limits How quantum algorithms could solve complex protein folding, molecular binding, and patient stratification problems The role of quantum optimization, error correction, and entanglement in solving medical challenges The potential of quantum-enhanced digital twins and quantum sensors for diagnostics and clinical research Why the next decade will be critical for building the foundations of quantum-powered healthcare Whether you’re in AI research, biotech, data science, or clinical innovation, this episode offers a visionary look into what comes after AI — and why quantum computation could become medicine’s ultimate game changer. About the Podcast AI for Pharma Growth is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget. As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses. This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more. Dr. Andree Bates LinkedIn | Facebook | Twitter

11/5/2025

For decades, medical research has been built around male data — leaving women dangerously underrepresented in clinical trials, drug development, and symptom understanding. The result? Misdiagnoses, ineffective treatments, and life-threatening blind spots in women’s healthcare. In this episode, Sonja Rincon, CEO and founder of MenoTracker, reveals how artificial intelligence is finally beginning to close the gender data gap in medicine. By using AI-powered analytics, machine learning, and real-world data, her platform is transforming how we understand perimenopause, menopause, and the broader landscape of women’s health research. Sonja explains how AI can: Detect patterns in women’s symptoms that doctors miss due to limited time and fragmented data Use mobile health apps, wearables, and electronic health records to build inclusive, large-scale data sets Address bias in healthcare algorithms and promote diversity in AI training data Enable personalised medicine and tailored treatments for women Empower women to track, understand, and advocate for their health From uncovering why AI algorithms have racial and gender bias to reimagining perimenopause tracking for 177 countries, this episode is a must-listen for anyone passionate about the future of AI in healthcare, digital health innovation, and gender equality in medicine. Sonja also highlights shocking realities — like how 58% of medical textbooks don’t cover menopause — and how AI can shorten the average diagnosis time for perimenopause from 7.4 years to just days. Whether you’re a healthcare innovator, data scientist, or simply someone who believes in inclusive innovation, this episode will reshape how you think about AI’s role in women’s health. About the Podcast AI for Pharma Growth is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget. As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses. This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more. Dr. Andree Bates LinkedIn | Facebook | Twitter

10/29/2025

What if your smartphone camera could detect your blood pressure, heart rate, stress levels, and early signs of disease — all in under a minute? In this groundbreaking episode, Remi Koscielny, CEO and Co-founder of Shen.AI, reveals how artificial intelligence is transforming everyday devices into powerful, non-invasive health monitoring tools. With over 5 billion smartphones in use worldwide — but half the global population lacking access to essential healthcare — Shen.AI is on a mission to democratise healthcare through AI-powered diagnostics. Remi explains how Shen.AI’s technology uses remote photoplethysmography (rPPG) and computer vision to read subtle color changes and micro-movements in your face, turning any front-facing camera into a virtual medical device capable of measuring heart rate variability, blood pressure, and even stress levels. In this episode, you’ll learn: How AI and computer vision can turn your smartphone into a clinical-grade health assessment tool The science behind rPPG and ballistocardiography, and how they detect vital signs through facial analysis Why Shen.AI’s contactless health monitoring is more inclusive across different skin tones and environments How this technology compares to wearables like Apple Watch and Fitbit, and why it may be even more accurate The global potential of AI-driven telehealth and preventative care How Shen.AI maintains data privacy and on-device processing, keeping sensitive health data secure The role of AI in proactive healthcare, early diagnosis, and global health equity How upcoming medical certifications (CE, FDA) will enable Shen.AI to expand into regulated clinical use Remi also shares powerful real-world stories where Shen.AI helped uncover miscalibrated medical devices and empowered individuals to take control of their health — anywhere, anytime. This episode is essential listening for anyone interested in the intersection of AI, healthcare innovation, and digital diagnostics, as well as health-tech founders, telemedicine providers, and clinicians exploring the future of remote patient monitoring. About the Podcast AI for Pharma Growth is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget. As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses. This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more. Dr. Andree Bates LinkedIn | Facebook | Twitter

10/22/2025

In this episode, we dive deep into how artificial intelligence (AI) is revolutionising digital marketing, from SEO optimisation to automated content creation, predictive analytics, and personalised campaigns. Our guest, Brandon Leibowitz, founder of SEO Optimisers, shares his expert insights on the future of AI-powered marketing, the best AI tools for SEO, and how to write effective ChatGPT prompts that actually rank. You’ll learn how marketers are using AI and machine learning to: Boost search engine rankings with optimised, AI-generated content Use ChatGPT and Google Gemini for smarter keyword research and content strategy Automate repetitive marketing tasks like ad copywriting, email campaigns, and social captions Detect low-performing content and revamp it with AI-driven analytics Personalise digital experiences based on target demographics and psychographics Balance automation with authentic customer connection Avoid AI pitfalls such as hallucinations, misinformation, and data privacy risks Brandon also explains how AI-enhanced SEO tools like SurferSEO, Ahrefs, and Keywords Everywhere are changing how marketers approach content optimisation. You’ll discover practical strategies for writing long-form prompts, refining Google Ads performance, and leveraging analytics for stronger conversion tracking. Whether you’re a small business owner, marketing professional, or agency leader, this episode will help you stay ahead in the age of AI-driven digital marketing and understand how to use these tools effectively — without losing the human touch. About the Podcast AI for Pharma Growth is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget. As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses. This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more. Dr. Andree Bates LinkedIn | Facebook | Twitter

10/15/2025

In this episode, we dive into the escalating war between AI and cybercrime — where artificial intelligence is both the ultimate defense and the greatest vulnerability. Our guest, Grant McCracken, founder of Dark Horse Security, reveals how AI-driven cybersecurity, machine learning detection systems, and automated threat analysis are transforming how we fight cyber threats in real time. From deepfake social engineering scams to AI-powered malware that learns and evolves, this conversation explores how both hackers and defenders are using AI to outsmart each other — and what that means for the future of digital security. We also discuss: How AI and machine learning are being deployed in cyber defense strategies Why small businesses (SMBs) are most at risk — and how Dark Horse Security is democratising cybersecurity The rise of AI-driven social engineering, deepfake attacks, and identity cloning The future of AI-powered threat detection, behavioral analysis, and zero-trust frameworks What happens when AI-powered attacks face AI-powered defenses How LLMs (large language models) are changing both hacking and protection The growing role of human error in breaches — and how AI might help prevent it What quantum computing could mean for encryption, AI, and the cybersecurity landscape Grant also shares his expert insights on the real-world implications of AI in cybersecurity, the cat-and-mouse race between attackers and defenders, and what organisations can do today to stay one step ahead of evolving digital threats. If you’re interested in AI security tools, penetration testing, ethical hacking, or how to protect your business from emerging AI-powered attacks, this episode is essential listening. About the Podcast AI for Pharma Growth is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget. As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses. This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more. Dr. Andree Bates LinkedIn | Facebook | Twitter

10/8/2025

Carlo Buckley, Founder and CEO of ID Health, joins the show to reveal how his company is transforming the future of personalised medicine through AI-driven, automated pharmaceutical manufacturing. For decades, personalised medicine has been limited by outdated manufacturing methods designed for mass production, not individual treatment. ID Health is changing that — pioneering a new way to produce personalised, patient-specific capsules at scale and at cost, combining multiple medications into one dose with digital dosing technology and automated precision systems. Buckley shares how AI, pharmacogenomics, and next-generation manufacturing are making individualised therapies accessible to millions, improving medication adherence, reducing polypharmacy, and cutting billions in medication waste. He also discusses how ID Health’s innovations could help patients safely taper off antidepressants, reduce side effects through precision dosing, and create a more sustainable, transparent, and patient-centered pharmaceutical ecosystem. About the Podcast AI for Pharma Growth is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget. As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses. This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more. Dr. Andree Bates LinkedIn | Facebook | Twitter

10/1/2025

In this episode, we explore how Explainable AI (XAI) is revolutionizing drug development, rare disease research, and precision medicine. Our guest, Frédéric Parmentier, Vice President of Data Science at Ariana Pharma, shares how their Explainable Artificial Intelligence (XAI) platform, KEM (Knowledge Extraction and Management), helps uncover critical biomarker signatures in small cohort clinical trials. Unlike traditional black box AI models, XAI delivers transparent, interpretable results that regulators and clinicians can trust—making it a game-changer for early-phase drug development, rare disease trials, and personalized medicine. We dive into: Why Explainable AI in clinical trials is essential for regulatory acceptance and scientific validation. How XAI can identify biomarkers of best responders in cohorts as small as 20–100 patients. Real-world examples where AI revealed insights that traditional statistics missed. The future of AI in drug development, precision medicine, and rare disease research. The difference between black box AI vs. Explainable AI in healthcare and why transparency matters. If you work in biopharma, clinical research, AI-driven healthcare, or drug discovery, this episode will give you powerful insights into how XAI can accelerate development, reduce trial failures, and enable personalized treatment strategies. About the Podcast AI for Pharma Growth is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget. As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses. This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more. Dr. Andree Bates LinkedIn | Facebook | Twitter

9/24/2025

How can AI-powered sleep monitoring transform clinical trials, drug development, and healthcare at home? In this episode, Jonas Krauss, Vice President of Business at Sleepiz AG, joins us to explore how contactless AI monitoring is redefining the way researchers and clinicians collect and analyze sleep data, vital signs, and patient health trends. Using radar-based sensors and artificial intelligence algorithms, Sleepiz can track breathing, heart rate, and sleep stages with medical-grade accuracy — all without touching the patient. This breakthrough technology is not only improving sleep disorder diagnosis but also helping pharmaceutical companies capture continuous, real-world data during clinical trials. Jonas shares: How AI and radar technology eliminate the need for invasive sleep studies with 30+ wires Why contactless monitoring generates higher compliance and better patient data The role of AI algorithms in detecting subtle health changes humans might miss How real-world data is transforming clinical trial design and drug development Why regulators like the FDA and EMA are demanding continuous monitoring in trials How this technology can tackle the global sleep disorder crisis (1B people affected, only 20% diagnosed) The potential of AI health monitoring to predict health deterioration before symptoms appear The future of personalized medicine and preventative healthcare powered by AI If you’re in clinical research, pharma, digital health, medtech, or healthcare innovation, this episode will give you a front-row seat into the future of AI-enabled patient monitoring and its role in shaping next-generation healthcare and drug trials. About the Podcast AI for Pharma Growth is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget. As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses. This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more. Dr. Andree Bates LinkedIn | Facebook | Twitter

9/17/2025

Can artificial intelligence really cut biomanufacturing timelines from years to hours? The answer is yes — and it’s already happening. In this episode, we sit down with Justin Byers, founder and CEO of Axio BioPharma, to explore how AI-driven biomanufacturing is transforming the development of monoclonal antibodies, biologics, and vaccines. By leveraging machine learning, digital twins, and predictive modeling, Axio is slashing development costs, reducing failure rates, and accelerating drug development pipelines like never before. Justin shares: How AI accelerates biomanufacturing from molecule design to full-scale production Why monoclonal antibodies are the ideal starting point for AI-enabled biologics development How digital twins of bioreactors and in silico models predict outcomes before wet lab experiments The role of AI in cell line selection, upstream fermentation, and downstream purification How predictive AI is reducing failed batches, impurities, and costly manufacturing runs The regulatory perspective — why the FDA is embracing AI models for drug development The future of AI in rare disease therapies and personalized medicine How startups and small biotech companies can now compete with Big Pharma thanks to AI-driven cost savings Byers explains how Axio’s platform is already saving clients 12–18 months and $1M+ per project, while unlocking opportunities to treat rare and ultra-rare diseases once considered commercially unviable. If you’re in biopharma, biotech, pharma manufacturing, or drug discovery, this conversation is essential listening. About the Podcast AI for Pharma Growth is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget. As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses. This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more. Dr. Andree Bates LinkedIn | Facebook | Twitter

9/10/2025

Over 90% of drugs fail during clinical development, costing billions and leaving patients without life-saving treatments. Why does the pharmaceutical industry face such a high drug development failure rate, and how can artificial intelligence change the story? In this episode, Vitalay Fomin, CEO and co-founder of Numenos AI, reveals how his team is rethinking clinical trials, biomarker discovery, and drug development with advanced AI technologies designed to predict patient response, reduce late-stage trial failures, and accelerate medicines to market. Vitalay shares: Why traditional clinical trial design contributes to such high failure rates How AI can predict drug response across different cancers and diseases The importance of moving beyond binary “responder / non-responder” models How Numenos AI uses cross-disease data to uncover hidden treatment insights The role of AI in drug toxicity prediction and improving patient safety Why the pharma industry needs a mindset shift toward embracing novel technologies The potential of AI to reduce Phase 2 and Phase 3 clinical trial failures A case study: how Numenos AI predicted the failure of a major immunotherapy target (TIGIT) This episode is essential listening for: Pharma executives and biotech leaders looking to cut R&D costs Clinical trial designers and data scientists in life sciences Healthcare innovators and AI in medicine researchers Investors in biotech, healthtech, and AI-driven drug discovery Patients and advocates who want to understand how AI can accelerate safe, effective treatments About the Podcast AI for Pharma Growth is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget. As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses. This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more. Dr. Andree Bates LinkedIn | Facebook | Twitter

9/3/2025

As artificial intelligence transforms the way we create, invent, and innovate, it’s also forcing the legal world to face unprecedented challenges. In this episode, Dr. Don Simmonds, IP law expert and founder of IPITEC, dives deep into the future of intellectual property law in the age of AI. From AI-generated art and machine-written books to patent disputes over AI-created inventions, this conversation unpacks the complex legal questions around AI copyright, AI patent law, and ownership rights in AI-assisted creation. Dr. Simmonds shares: Why the key legal question right now is “what is enough?” when determining human vs. AI contribution How courts and legislators are wrestling with AI authorship, inventorship, and public domain issues The impact of AI tools like ChatGPT on legal work and argument drafting Why major corporations may deliberately drag out AI-related lawsuits for strategic advantage The differences between US and EU approaches to AI regulation, from revenue rights to AI privacy laws How AI deepfakes, voice cloning, and synthetic media are challenging existing copyright frameworks The looming question of whether AI could ever be granted rights — and what would have to change first Whether you’re a lawyer, creator, entrepreneur, tech founder, or policy maker, this episode will help you understand the fast-evolving intersection between artificial intelligence and intellectual property protection — and how to navigate it in your business or creative practice. About the Podcast AI for Pharma Growth is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget. As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses. This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more. Dr. Andree Bates LinkedIn | Facebook | Twitter

8/27/2025

In this cutting-edge episode, we explore how Edge AI is transforming drug discovery and revolutionising laboratory workflows, real-time molecular analysis, and protein folding predictions—all at the source of data collection. Joining us is Nuri Cankaya, Vice President of Commercial Marketing at Intel Corporation, and a renowned thought leader in AI and healthcare innovation. You'll discover how AI at the edge—enabled by on-device NPUs, GPUs, and CPUs—is unlocking privacy-preserving, high-performance computing in the most sensitive environments, such as clinical labs and pharmaceutical R&D centers. Nuri shares his deep experience in AI, discusses hardware configurations for edge deployments, and provides real-world examples of AI accelerating high-throughput screening, compound discovery, and target validation. Key Topics: What is Edge AI and how it differs from cloud-based AI How real-time AI in the lab enables faster, cheaper drug discovery Hardware requirements: NPU, GPU, CPU integration for edge computing The role of AlphaFold and protein folding prediction in therapeutic development Use cases in molecular screening, genomics, and clinical trial simulations How Edge AI preserves data privacy and complies with GDPR and HIPAA Predictions for AGI (Artificial General Intelligence) and Quantum Computing in healthcare Strategic advice for pharma leaders and biotech innovators looking to pilot AI The energy efficiency and sustainability gains from Edge AI vs. cloud AI About the Podcast AI for Pharma Growth is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget.  As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses.  This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more.  Dr. Andree Bates LinkedIn | Facebook | Twitter

8/20/2025

In this eye-opening episode, we sit down with Julia Komissarchik, CEO and Co-Founder of Glendor Inc., to explore the rapidly evolving intersection of AI in healthcare, medical data privacy, and patient data protection. With AI transforming clinical decision-making, diagnostics, and health research, traditional privacy approaches like de-identification are no longer sufficient. Julia, a seasoned expert in AI and a multi-patent holder, explains why anonymised health data is still vulnerable to re-identification by AI models, and how privacy-preserving technologies like federated learning, differential privacy, homomorphic encryption, and secure multi-party computation can help. She discusses real-world breaches, regulatory challenges with HIPAA and GDPR, and the importance of patient consent and ethical AI governance. This episode is a must-listen for AI researchers, health tech entrepreneurs, data scientists, hospital CIOs, privacy advocates, and anyone navigating the future of AI-powered healthcare. Key Topics Covered: Why traditional anonymisation methods are failing in the age of AI-driven healthcare How AI models can re-identify patients using "innocuous" data like medication patterns and X-ray imagery The risks and limitations of synthetic data in clinical AI development The critical role of federated learning, differential privacy, and homomorphic encryption Why current HIPAA and GDPR regulations may be falling short for modern healthcare applications The urgent need for multi-modal data sharing frameworks that are both privacy-conscious and research-enabling Real-world examples of data privacy breaches and their financial and reputational consequences Inspiring success stories from ARPA-H’s INDEX initiative and South Korea’s AI health data sharing model The call for a new era of algorithmic transparency, AI ethics, and patient empowerment in health data use About the Podcast AI for Pharma Growth is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget.  As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses.  This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more.  Dr. Andree Bates LinkedIn | Facebook | Twitter

8/13/2025

Can AI truly revolutionize molecular biology if it’s built on unreliable data? In this game-changing episode, we speak with Dr. Jonathon O'Brien, founder and CEO of Golgi, about one of the most critical—and often overlooked—issues in biomedical AI: data reliability. With a background in biostatistics, proteomics, and machine learning, Dr. O’Brien shares how Golgi’s AI-powered computational platform is helping pharma and biotech giants like Johnson & Johnson tackle the reproducibility crisis in mass spectrometry-based proteomics. We explore how his patented platform predicts measurement variability using data features most researchers overlook—and how this unlocks faster, cheaper, and more reliable drug discovery. What You’ll Learn: Why AI models in biology often fail due to bad training data How Golgi predicts data reliability without replicates Why reproducibility and variance prediction are key to high-throughput drug screening Real-world examples from pharma and stealth biotech clients The cultural and technical barriers to trustworthy AI in life sciences Lessons from AlphaFold and Basecamp Research on reliable ML data use Best practices for applying machine learning in molecular biology How human expertise is still vital in AI-driven biomedical innovation About the Podcast AI for Pharma Growth  is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget.  As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses.  This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more.  Dr. Andree Bates LinkedIn | Facebook | Twitter

8/6/2025

In this episode, we delve into the transformative power of real-world data (RWD) in modern healthcare. Our guest, Ted Sweetser, Vice President of Strategic Advertising and Partnerships at PurpleLab, shares expert insights on how real-world data is driving innovation in patient outcomes, market access, and public health strategy. From electronic health records (EHRs) and insurance claims data to wearable health technology and social determinants of health (SDOH), this conversation explores how diverse data sources are reshaping the pharmaceutical, payer, and provider landscapes. Topics Covered: What is real-world data and how it differs from traditional clinical trial data The rise of RWD in health economics and outcomes research (HEOR) How RWD supports regulatory decisions and drug development Leveraging AI and cloud computing to accelerate healthcare insights Case studies: Using RWD to address access inequalities and improve patient care How RWD informs insurance coverage, pricing strategies, and treatment protocols Ethical frameworks and HIPAA-compliant practices for data de-identification The future of proactive healthcare powered by predictive analytics Key Takeaways: Real-world data enables evidence generation at scale, supporting faster, cost-effective decisions in healthcare. Insurance companies and pharma use RWD to identify underserved populations, optimize formulary decisions, and validate the ROI of new drugs like GLP-1s. AI-powered platforms like PurpleLab unify fragmented data sources while protecting patient privacy and maintaining HIPAA compliance. Preventative healthcare strategies and public health interventions are increasingly driven by granular, geospatial, and demographic data. About the Podcast AI for Pharma Growth  is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget.  As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses.  This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more.  Dr. Andree Bates LinkedIn | Facebook | Twitter

7/30/2025

In this episode, former FDA leader and current SVP of Regulatory and Quality at Ariana Data Intelligence, Dr. Frederico Goodsaid, shares cutting-edge insights on how artificial intelligence (AI) is reshaping the landscape of drug discovery and development — particularly in the treatment of rare and orphan diseases. From breaking down the FDA's new guidance on AI to explaining why credibility now matters more than explainability, this conversation offers essential takeaways for professionals in biotech, pharma, regulatory affairs, clinical trials, and digital health. In This Episode, You'll Learn: How the FDA defines and regulates AI tools in drug development The evolving concept of “credibility” in machine learning models Why AI is essential for rare disease research with small patient populations Challenges with black-box algorithms and how to overcome them How real-world evidence and genomic data are driving drug repurposing The FDA's stance on continuous learning AI systems Strategic advice for pharma companies adopting AI under regulatory scrutiny About the Podcast: AI for Pharma Growth  is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget. As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses. This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more. Dr. Andree Bates LinkedIn | Facebook | Twitter

7/23/2025

Why empathy, ethics, and education must remain central to AI adoption Predictions for the next 500 years of human-AI co-evolution This conversation blends AI philosophy, tech strategy, and personal productivity in a way that will challenge your assumptions and give you actionable ideas to stay relevant in the AI-pIn this eye-opening episode, we’re joined by Mark Andrews, founder and CEO of AI Prophets, for a deep-dive into how artificial intelligence (AI) is transforming human evolution, cognition, work, and even our biology. Together, we explore: How AI is evolving from a tool to a symbiotic part of the human experience The merging of human consciousness with technology through brain-computer interfaces and AI-driven implants Why large language models (LLMs) like ChatGPT are only the beginning Transhumanism, wearable tech, and the dawn of digital biology How overdependence on AI may cost us our authentic voice and cognitive agility The role of data science and prompt engineering in unlocking AI’s real-world potential About the Podcast: AI for Pharma Growth is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget.  As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses.  This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more.  Dr. Andree Bates LinkedIn | Facebook | Twitter

7/16/2025

In this powerful episode, we dive deep into how artificial intelligence (AI) and automation are transforming regulatory submissions and medical writing in the biopharmaceutical industry. Our guest, Tim Martin, Vice President of Product at Yseop, shares expert insights on how AI-driven tools are revolutionising workflows, cutting document creation times by over 70%, and helping accelerate drug approval timelines — potentially saving $1–$5 million per day for pharma companies. In this episode, you’ll learn: How AI reduces time-to-market for clinical submissions Ways automation ensures regulatory compliance and data security How AI supports regulatory document generation like clinical study reports (CSRs) and patient narratives The role of AI in maintaining accuracy, consistency, and formatting compliance across submission packages Insights into the adoption of AI by both Big Pharma and emerging biotech companies What regulatory agencies like the FDA and EMA say about AI-generated content How platforms like Veeva integrate with AI solutions to streamline document workflows Future-proof skills medical writers will need in an AI-powered landscape Whether you're a regulatory affairs professional, medical writer, clinical operations leader, or part of a biotech startup, this episode provides actionable knowledge about AI in life sciences, automated regulatory writing, and digital transformation in pharma. About the Podcast: AI for Pharma Growth  is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget.  As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses.  This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more.  Dr. Andree Bates LinkedIn | Facebook | Twitter

7/9/2025

In this episode, we sit down with Dr. Marschall Runge - CEO of Michigan Medicine and Dean of the University of Michigan Medical School - to explore how artificial intelligence (AI) is transforming the entire landscape of drug discovery, clinical trial design, and precision medicine. With deep insights from decades of leadership across biotechnology, genomics, and translational research, Dr. Runge shares exclusive stories on how pharmaceutical giants and biotech startups are using AI to compress years of research into days, optimize molecule design, and personalize treatments with astonishing accuracy. From protein folding to AI-generated molecules, and from digital twins to FDA-approved synthetic data in trials, this episode is a must-listen for anyone working in: Pharmaceutical innovation AI and machine learning in healthcare Precision medicine Clinical trial optimization Healthtech entrepreneurship Biotech investment and strategy Topics Covered In This Episode: How AI is accelerating drug discovery timelines from years to days Real-world case studies using AI to find novel inhibitors The rise of digital twins, synthetic data, and AI-driven clinical trials Democratization of drug development for startups and biotech founders Data bias, model design, and ethical considerations in AI-driven research Predictive accuracy of AI-designed drugs vs traditional pharma R&D The future of personalized medicine powered by omics and machine learning The impact of large tech companies (Google, Apple, NVIDIA) entering pharma Exciting breakthroughs in anti-aging and longevity drug research Dr. Runge's predictions for the next 10 years in healthcare and AI About the Podcast: AI for Pharma Growth  is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget.  As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses.  This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more.  Dr. Andree Bates LinkedIn | Facebook | Twitter

7/2/2025

This powerful episode dives into one of the most urgent issues in modern healthcare; how current AI systems in clinical trials are missing the mark for diverse and underrepresented patient populations, especially in oncology and neurology. Guest Dr. Joseph Geraci, mathematician, quantum machine learning scientist, and inventor of Netramark, breaks down how most AI models today are built on biased, homogeneous datasets - and what needs to change to truly unlock the potential of precision medicine. In this episode, you will hear:  How standard AI systems often misdiagnose patients due to biased training data The critical differences in AI model performance in oncology vs. neuroscience Why small data is the new frontier for clinical trial success The overlooked power of patient attitudes, placebo responses, and behavioral factors How explainable AI and causal modeling are reshaping the future of drug discovery Challenges and solutions around AI bias, patient privacy, and regulatory strategy The emerging role of digital twins, transcriptomic time series, and multi-dimensional data fusion in advancing equitable drug development Whether you're leading a clinical trial, innovating in pharmaceutical AI, or shaping policy around FDA/EMA approvals for AI tools, this episode is your roadmap to building smarter, fairer, and more impactful healthcare technologies. About the Podcast: AI for Pharma Growth  is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget.  As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses.  This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more.  Dr. Andree Bates LinkedIn | Facebook | Twitter

6/25/2025

Leveraging AI to detect mental states and prevent catastrophic events in mental health This episode dives into a revolutionary advancement in AI-powered mental health technology. Francois Gand, founder and CEO of Nuro, introduces Mentis - a non-invasive neurotechnology platform capable of detecting, tracking, and predicting mental states in real time. From preventing suicide and catastrophic errors in high-risk professions to enabling communication for the paralyzed, Mentis is a game-changer in brain-computer interface (BCI) innovation. Discover how AI-driven cognitive monitoring is transforming how we assess and respond to fatigue, anxiety, PTSD, cognitive performance, and emotional distress - all through a seemingly simple, wireless headband. In this episode, you'll learn: How Mentis monitors real-time mental states like attention, fear, fatigue, and anxiety Use cases in suicide prevention, palliative care, PTSD intervention, and clinical diagnostics How non-invasive BCI restores communication for voiceless and paralyzed patients The significance of mental state awareness in aviation, defense, athletics, and healthcare Validation with McGill University showing over 97% accuracy in mental state classification Data privacy protocols: fully encrypted, local, and user-controlled data handling Potential for integration in clinical trials, pharma R&D, and frontline therapeutic settings The evolving role of AI in psychiatry, mental health diagnostics, and brain state analytics This conversation offers a powerful glimpse into the future of mental health monitoring, AI-enhanced cognitive tools, and human-AI interaction through ethical, high-precision neural signal analysis. About the Podcast: AI for Pharma Growth  is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget.  As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses.  This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more.  Dr. Andree Bates LinkedIn | Facebook | Twitter

6/18/2025

In this expert-led episode, Christopher Rudolf, CEO of Volv Global, unpacks how artificial intelligence is revolutionizing rare disease detection and knowledge generation. With over 30 years in data science and medical informatics, he shares how machine learning is being used to solve two of the biggest challenges in rare disease: finding undiagnosed patients and generating actionable clinical insights. This conversation is essential for professionals in healthcare innovation, data analytics, life sciences, and rare disease advocacy. Discover how AI is shortening diagnostic journeys, overcoming data limitations, and uncovering new phenotypic patterns - especially for ultra-rare conditions often overlooked by traditional systems. In this episode, you will hear: How AI pinpoints hidden rare disease patients using population-scale clinical, claims, and genetic data Why traditional EHR data and diagnostic coding fail rare disease detection - and how AI models fill the gap The challenge of balancing specificity vs. sensitivity in identifying true positives How natural history studies and patient-generated data are helping refine precision medicine What AI-generated insights reveal that clinical literature often misses The role of patient advocacy groups in training better algorithms and ensuring relevance Privacy, redaction, and regulatory concerns - and how to responsibly handle sensitive patient data The limitations of synthetic data, federated learning, and digital twins in ultra-rare conditions How bias in healthcare data can mislead AI - and what safeguards can mitigate disparities What’s next: scaling ethically, lowering costs, and building trust between AI tools and clinicians About the Podcast: AI for Pharma Growth  is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget.  As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses.  This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more.  Dr. Andree Bates LinkedIn | Facebook | Twitter

6/11/2025

This episode dives deep into how synthetic medical imaging is revolutionizing the development of AI in healthcare. Rayan Sadri, founder and CEO of Carez AI, explains how his team uses diffusion models and GANs to create fully anonymized, regulator-friendly datasets that dramatically accelerate the development of diagnostic tools - even for rare conditions and underserved populations. Discover how synthetic data eliminates the bottlenecks of traditional medical datasets by solving challenges around privacy, annotation costs, data scarcity, and demographic bias. From MRI and CT scans to X-rays, ultrasound, and RF signal data, learn how this technology enables faster, safer, and more inclusive AI model training. Whether you're building healthcare AI products, optimizing clinical research pipelines, or scaling life sciences innovation, this conversation uncovers practical, scalable strategies for deploying high-quality synthetic datasets that meet clinical standards and regulatory requirements. In this episode, we discuss: What is synthetic imaging and how it differs from traditional datasets The four-step process of creating medically accurate synthetic images Balancing visual quality, anatomical accuracy, and data diversity Addressing data bottlenecks in medical AI development FDA perspectives on synthetic data and regulatory compliance Applications of synthetic data in reducing contrast media risks Conditional generation for underrepresented patient demographics Ethical concerns: privacy, bias, traceability, and clinical relevance How synthetic data empowers faster and more inclusive AI breakthroughs The future of AI and synthetic imaging in global healthcare This episode is tailored for Medical AI startups and healthtech founders, clinical researchers and radiologists, AI engineers and data scientists in life sciences, digital health policy makers and FDA collaborators, academic researchers exploring synthetic data applications and Investors and stakeholders in health innovation About the Podcast: AI for Pharma Growth  is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget.  As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses.  This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more.  Dr. Andree Bates LinkedIn | Facebook | Twitter

6/4/2025

In this essential episode, we dive deep into the evolving intersection of AI in the workplace and copyright law with expert guest Lauren McLeod Tulloch, Vice President and Managing Director at the Copyright Clearance Center. As businesses increasingly adopt generative AI tools like ChatGPT, Claude, and other LLMs, the legal and compliance landscape is rapidly shifting. Lauren shares actionable insights on how organizations can protect themselves from copyright infringement, manage AI-generated content, and implement clear AI usage policies. What You’ll Learn In This Episode: Who owns AI-generated content: employee vs employer vs AI provider Why “work for hire” and IP clauses in employment contracts matter more than ever What constitutes derivative works and how they can trigger copyright issues How international copyright laws (e.g., US vs EU) affect global companies The importance of AI tool terms of service and avoiding hidden legal pitfalls How organizations can use collective licensing to legally integrate AI into their workflows Real-world cases like the Thomson Reuters v Ross and Getty Images lawsuits impacting AI training data About the Podcast: AI for Pharma Growth  is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget.  As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses.  This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more.  Dr. Andree Bates LinkedIn | Facebook | Twitter

5/28/2025

In this eye-opening episode, we explore how cutting-edge AI is revolutionizing the legal and compliance industry, particularly for contract lifecycle management, litigation preparation, and regulatory compliance. Our guest is Jaegar Glucina, Chief of Staff at Luminance—an AI-powered legal software platform trusted by over 700 organizations worldwide, including global law firms and corporate legal departments. Jaeger shares deep insight into how Luminance’s proprietary large language models are driving change across complex legal workflows. 💼 Whether you're in pharmaceuticals, healthcare, finance, or any other highly regulated industry, this is a must-listen for legal professionals, GCs, compliance officers, and AI-curious executives. 💡 Key Topics Covered: 🚀 How AI accelerates contract generation, negotiation, and analysis 🧠 Domain-specific large language models (LLMs) vs. generalist AI 🔍 Unsupervised learning for legal document discovery & risk detection 🔁 AI-powered contract review with no tagging or manual training needed 🧾 Reducing costs and response times in force majeure and pandemic clause audits ⚖️ Addressing AI bias, accuracy demands, and jurisdictional differences 🛡️ Ensuring data security and maintaining attorney-client privilege with legal AI 🧑‍⚖️ Why law firms must evolve beyond billable hours to remain competitive About the Podcast: AI for Pharma Growth  is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget.  As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses.  This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more.  Dr. Andree Bates LinkedIn | Facebook | Twitter

5/21/2025

In this episode, discover how AI (artificial intelligence) and AR (augmented reality) are transforming neurosurgery, surgical training, and the entire operating room experience. Vladimir Verbulskii, CEO of Argus AI, shares how their cutting-edge technology is enabling surgeons to see inside the human body with unmatched clarity, boosting precision, reducing risks, and improving patient outcomes. Explore how 3D medical imaging, real-time anatomical overlays, and AI-powered diagnostics are making once “inoperable” brain tumors accessible through minimally invasive keyhole procedures. Learn how AI segmentation and AR visualization are empowering both senior and junior surgeons, reducing surgical learning curves, and accelerating recovery times. Ideal for anyone in healthcare technology, surgical innovation, medical education, or hospital decision-making, this episode reveals the future of surgery—delivered through a simple pair of smart glasses. What You’ll Learn: How AI and AR are currently used in cranial neurosurgery What keyhole brain surgery is and how tech enables it The role of 3D segmentation and anatomical labeling in AI training How AR goggles improve surgical planning and precision The regulatory challenges of launching AI medical devices Why educational institutions are a vital path to market for medtech startups The potential for remote surgery collaboration through immersive visualization About the Podcast: AI for Pharma Growth  is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and change-makers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget.  As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses.  This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more.  Dr. Andree Bates LinkedIn | Facebook | Twitter

5/14/2025

In this cutting-edge episode of the podcast, we explore the powerful intersection of artificial intelligence (AI), wearable technology, and the pharmaceutical industry. Our special guest, Marco Benitez, CEO and co-founder of Rook AI, shares how real-time biometric data from wearables like Apple Watch, Dexcom, and Oura Ring is revolutionizing clinical trials, remote patient monitoring, and digital health solutions. From HRV (heart rate variability) to glucose levels, discover how wearable biosensors, when combined with advanced AI algorithms, enable early detection of adverse events, improved patient engagement, and real-world evidence for drug efficacy. If you're in healthtech, pharma R&D, clinical operations, or digital therapeutics, this episode is a must-listen! 🔍 What You'll Learn in This Episode: How AI and wearable data are reshaping the future of clinical research The role of real-time biometric monitoring in early intervention and patient safety How Rook AI’s API connects over 300 wearables for seamless health data integration Key benefits for pharmaceutical companies, CROs, and healthcare providers Real-world case studies in oncology, vaccines, diabetes, and cardiac care Insights into data privacy (HIPAA/GDPR), security, and ethical considerations The future of personalized medicine, preventive care, and remote diagnostics Emerging technologies like CGMs, wearable rings, and even ingestible sensors 🎯 Who Should Listen? This episode is perfect for: Pharma executives exploring digital transformation Healthcare innovators looking to implement wearable tech Clinical trial managers & CROs adopting AI-driven tools Startup founders and digital health entrepreneurs Medical researchers interested in real world data (RWD) Investors in wearable tech and health AI About the Podcast: AI for Business Growth  is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Business Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget.  As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses.  This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more.  Dr. Andree Bates LinkedIn | Facebook | Twitter

5/7/2025

In this must-listen episode of AI for Business Growth, host Dr. Andre Bates is joined by Damond Rasheed, Executive Director at Opyl (makers of Trial Key, an AI SaaS platform for clinical trial design). Together, they unpack how artificial intelligence is transforming rare disease clinical trials, solving real-world bottlenecks in patient recruitment, adaptive trial design, and biostatistical validation using advanced machine learning models and real-world evidence (RWE). Damond shares candid insights from his journey—starting as a card-counting economist turned AI innovator—and details how AI can simulate and optimize clinical trial outcomes, even with limited datasets, fragmented information, or under-researched rare diseases. Learn how platforms like Trial Key are helping biotech and pharma companies: Predict clinical trial success probabilities Optimize patient cohort sizes and timelines Integrate digital biomarkers and real-world data for better decision-making Address ethical considerations and data bias Expand globally across the US, UK, and beyond Whether you're a clinical research professional, digital health entrepreneur, AI data scientist, or healthcare investor, this episode is packed with actionable takeaways on leveraging AI to reduce costs, shorten trial timelines, and increase approval success—especially in rare and complex disease landscapes. What You’ll Learn in This Episode: How AI models predict clinical trial success with high accuracy (AUC ~0.8) Why rare disease trials benefit disproportionately from AI optimization Challenges in accessing high-quality patient-level data The ethical imperative of simulating trials before involving human patients How language models like ChatGPT are being used to analyze unstructured clinical trial data AI vs. traditional power tests in enrollment planning Use of synthetic data to reduce bias in training datasets How Opal is driving trial innovation globally from Australia to the US and UK About the Podcast: AI for Business Growth  is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and change-makers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Business Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget.  As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses.  This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more.  Dr. Andree Bates LinkedIn | Facebook | Twitter

4/30/2025

In this episode of AI for Business Growth, Dr. Andre Bates sits down with Michael Buckbee, co-founder of Knowatoa, to explore the fast-evolving world of AI-powered search, especially in healthcare and SEO strategy. From ChatGPT hallucinations to brand sentiment in AI rankings, this conversation dives deep into the real-world use cases, risks, and transformational opportunities of using large language models (LLMs) like ChatGPT, Perplexity, and Google Gemini to drive visibility, improve patient outcomes, and reshape the digital strategy landscape. What You’ll Learn in This Episode: ✅ Why AI search is revolutionizing healthcare search and clinical decision support ✅ How LLMs like ChatGPT and Claude are redefining SEO for businesses ✅ The rise of brand sentiment scoring and what it means for AI search visibility ✅ The dangers and misconceptions around AI hallucinations and data privacy ✅ Why AI search engines need better grounding in medical databases ✅ How AI tools like GPT can act as "your most popular but least trained employee" ✅ The future of local AI models, search ranking optimization, and content strategies ✅ Practical advice for pharma marketers, healthtech companies, and SEO professionals ✅ The BISCUIT framework for SEO success in AI-driven ecosystems About the Podcast: AI for Business Growth  is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Business Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget.  As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses.  This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more.  Dr. Andree Bates LinkedIn | Facebook | Twitter

4/23/2025

In this must-listen episode, Dr. Andre Bates sits down with James Hamet, founder and CEO of Vistim Labs, as he unveils a groundbreaking EEG technology that could transform how we understand and treat neurodegenerative diseases like Alzheimer's and Parkinson's.  In this eye-opening edition of AI for Business Growth, Hamet reveals a cutting-edge brain mapping technique that can reproduce PET scan images using advanced AI and EEG technology, detect neurological disease progression with unprecedented precision, identify individual neuron health before complete deterioration, provide personalized treatment recommendations by matching patient brain maps, potentially reduce invasive medical procedures by up to 50%, enable real-time monitoring of treatment effectiveness, and expand diagnostic capabilities across multiple neurological conditions. Key Insights: Technology can map brain function with higher resolution than traditional MRI AI assists doctors by suggesting targeted treatment options, not replacing them Potential to revolutionize clinical trials and patient care Non-invasive, quick testing method (2-minute setup) Applicable to conditions like Alzheimer's, Parkinson's, schizophrenia, and traumatic brain injury About the Podcast: AI for Business Growth  is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Business Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget.  As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses.  This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more.  Dr. Andree Bates LinkedIn | Facebook | Twitter

4/16/2025

In this must-listen episode, Dr. Andre Bates sits down with Soner Hacihaliloglu, founder and CEO of PONS Tech, to explore how Generative AI (GenAI) and ultrasound technology are combining to radically improve medical imaging, early detection, and preventive healthcare. 🚀 Key Takeaways: How AI-driven image enhancement is solving the challenges of low-quality ultrasound images. Why mobile and decentralized ultrasound imaging is key to democratizing healthcare access. The unique role of AI in triaging patients, reducing unnecessary hospital admissions, and alleviating pressure on overworked radiologists. Powerful real-world case studies from Nigeria and Eastern Europe showing the impact of AI-enhanced imaging in underserved communities. How synthetic data and enhanced datasets are helping build robust AI models with improved accuracy and diversity. The future of home-based scanning and real-time telemedicine supported by AI-powered imaging tools. Practical insight into how this tech integrates seamlessly into existing clinical workflows, minimizing disruption for healthcare providers. Cost-saving implications of early diagnosis in oncology, chronic disease management, and senior care. How patient and doctor feedback is shaping next-gen AI diagnostic tools and decentralized care models. About the Podcast: AI for Business Growth  is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future. This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights. AI For Business Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget.  As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses.  This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more.  Dr. Andree Bates LinkedIn | Facebook | Twitter